Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.097
Neutral
RSI(14)
47.490
Neutral
STOCH(KDJ)(9,3,3)
57.468
Sell
ATR(14)
0.238
High Vlolatility
CCI(14)
52.736
Neutral
Williams %R
32.911
Buy
TRIX(12,20)
-0.331
Sell
StochRSI(14)
34.777
Sell
Search
LifeVantage Corp
LFVNAdd to Watchlist
6.340USD
-0.090-1.40%
Close 07-29 16:00（ET）Quotes delayed by 15 min
79.94MMarket Cap
13.76P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-1.40%
5 Days
-0.16%
1 Month
+2.26%
6 Months
+16.12%
Year to Date
+2.92%
1 Year
-50.89%
Key Figures
6.430Open
6.430High
67.18KVolume
13.76P/E TTM
13.96P/E Dynamic
0.180Dividend TTM
0.53%Turnover Ratio
6.430Prev. Close
6.260Low
327.89KTurnover
8.15P/E Static
2.40P/B
2.84%Div Yield TTM
8.25%ROA
15.00052wk High
0.94Volume Ratio
9.80MNet Profit
12.61MShares
0.4608EPS TTM
0.65Beta
17.08%ROE
3.90052wk Low
2.64%Amplitude
79.02%Gross Margin
79.94MMarket Cap
0.65Reward/Risk
4.68%Risk Rate
TradingKey Stock Score of LifeVantage Corp
Currency: USD Updated: 2026-07-29Key Insights
LifeVantage Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 59 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.00.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
LifeVantage Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
LifeVantage Corp Highlights
StrengthsRisks
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 228.53M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 21.08%.
Undervalued
The company’s latest PE is 13.78, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 9.36M shares, decreasing 5.71% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 24.33K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.33.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
7.000
Target Price
+9.89%
Upside Space
LifeVantage Corp News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
2
analysts
Buy
Current Rating
7.000
Target Price
+9.89%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
LifeVantage Corp
LFVN
2
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
34
Pfizer Inc
PFE
32
1
2
3
...
32
Indicators
Moving Average
Indicators
Value
Direction
MA5
6.390
Sell
MA10
6.334
Buy
MA20
6.283
Buy
MA50
6.921
Sell
MA100
5.862
Buy
MA200
6.142
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
LifeVantage Corp Info
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Ticker SymbolLFVN
CompanyLifeVantage Corp
CEOFife (Steven R)
Websitehttps://www.lifevantage.com/
Shareholders
Related Instruments
-0.75%
-0.41%
+0.49%
+0.16%
-1.07%
-0.64%
-1.34%
+1.26%
-1.15%
-0.30%
-0.72%
-1.36%
-0.03%
-0.94%
-1.44%
0.00%
+0.24%
+1.34%
+1.29%
-1.45%Popular Instruments
51690.200
+132.200 (+0.26%)
27389.700
+275.900 (+1.02%)
7346.800
+44.000 (+0.60%)
14501.000
-185.000 (-1.26%)
62073.000
+1144.000 (+1.88%)
6250.200
+29.700 (+0.48%)
83.010
-0.931 (-1.11%)
338.360
-1.720 (-0.51%)
190.240
-6.770 (-3.44%)
4053.660
-13.480 (-0.33%)
FAQs
What is the current price of LifeVantage Corp (LFVN)?
The current price of LifeVantage Corp (LFVN) is 6.34.
What is the symbol of LifeVantage Corp?
The ticker symbol of LifeVantage Corp is LFVN.
What is the 52-week high of LifeVantage Corp?
The 52-week high of LifeVantage Corp is 15.00.
What is the 52-week low of LifeVantage Corp?
The 52-week low of LifeVantage Corp is 3.90.
What is the market capitalization of LifeVantage Corp?
The market capitalization of LifeVantage Corp is 79.94M.
Is LifeVantage Corp (LFVN) currently rated as Buy, Hold, or Sell?
According to analysts, LifeVantage Corp (LFVN) has an overall rating of Buy, with a price target of 7.00.
What is the Earnings Per Share (EPS TTM) of LifeVantage Corp (LFVN)?
The Earnings Per Share (EPS TTM) of LifeVantage Corp (LFVN) is 0.80.